DUBLIN–(BUSINESS WIRE)–The “Collagen Solutions Plc (COS) – Product Pipeline Analysis, 2019 Update” company profile has been added to ResearchAndMarkets.com’s offering.
Summary
Collagen Solutions Plc (Collagen Solutions), formerly Healthcare Investment Opportunities Plc, is a medical device company that develops, manufactures and supplies medical grade collagen biomaterials and components. The company offers sourcing and supply of high grade collagen; provision of functional collagen bio-materials; and contract manufacture of collagen-based products and medical devices, among others. It provides bovine spongiform encephalopathy (BSE)-free bovine biomaterials to meet customer specifications including bone, cartilage and tendon, and veins and blood vessels. Collagen Solutions’ products are used in research, diagnostics, medical devices and regenerative medicine. The company offers product development and contract manufacturing services including technology transfer and regulatory support to pharmaceutical and medical device companies. It has operations in the UK, the US, South Korea and New Zealand. Collagen Solutions is headquartered in Glasgow, the UK.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Collagen Solutions Plc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Key Topics Covered:
- Collagen Solutions Plc Company Overview
- Collagen Solutions Plc Company Snapshot
- Collagen Solutions Plc Pipeline Products and Ongoing Clinical Trials Overview
- Collagen Solutions Plc – Pipeline Analysis Overview
- Collagen Solutions Plc – Key Facts
- Collagen Solutions Plc – Major Products and Services
- Collagen Solutions Plc Pipeline Products by Development Stage
- Collagen Solutions Plc Ongoing Clinical Trials by Trial Status
- Collagen Solutions Plc Pipeline Products Overview
- Bone Graft Substitutes
- Bone Graft Substitutes Product Overview
- ChondroMimetic
- ChondroMimetic Product Overview
- ChondroMimetic Clinical Trial
- Collagen-Based Delivery System – Parkinson’s Disease
- Collagen-Based Delivery System – Parkinson’s Disease Product Overview
- Fibrillar Collagen
- Fibrillar Collagen Product Overview
- Heart Valve Device
- Heart Valve Device Product Overview
- Collagen Solutions Plc – Key Competitors
- Collagen Solutions Plc – Key Employees
- Collagen Solutions Plc – Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Collagen Solutions Plc, Recent Developments
- Nov 13, 2019: Collagen Solutions: Directorate Change
- Jul 09, 2019: Collagen Solutions: Final results
- Jul 09, 2019: Collagen Solutions: Directorate change
- Jun 06, 2019: Collagen Solutions: Appointment of non-executive director
- Apr 09, 2019: Collagen Solutions provides trading update
- Jan 31, 2019: ChondroMimetic update distribution agreement with Indonesian partner and update on CE mark process
- Jan 07, 2019: Award of 1.54 million Scottish Enterprise grant non-dilutive funding to support growth Strategy
- Jan 07, 2019: Collagen Solutions: Award of 1.54 million Scottish Enterprise Grant
- Dec 04, 2018: Collagen Solutions: Interim results for the six months ended 30 September 2018
- Sep 03, 2018: Collagen Solutions: Board appointments
- Appendix
- Methodology
- About the Author
- Contact Us
- Disclaimer
Companies Mentioned
- Smith & Nephew Plc
- ConvaTec Group Plc
- Advanced Medical Solutions Group Plc
For more information about this company profile visit https://www.researchandmarkets.com/r/xfkwrx
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900